Neurocrine Biosciences Statistics
Total Valuation
NBIX has a market cap or net worth of $12.52 billion. The enterprise value is $12.07 billion.
| Market Cap | 12.52B |
| Enterprise Value | 12.07B |
Important Dates
The next estimated earnings date is Thursday, July 31, 2025, before market open.
| Earnings Date | Jul 31, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
NBIX has 98.97 million shares outstanding. The number of shares has increased by 0.78% in one year.
| Current Share Class | 98.97M |
| Shares Outstanding | 98.97M |
| Shares Change (YoY) | +0.78% |
| Shares Change (QoQ) | -0.39% |
| Owned by Insiders (%) | 1.11% |
| Owned by Institutions (%) | 98.31% |
| Float | 97.78M |
Valuation Ratios
The trailing PE ratio is 42.79 and the forward PE ratio is 17.14. NBIX's PEG ratio is 2.67.
| PE Ratio | 42.79 |
| Forward PE | 17.14 |
| PS Ratio | 5.27 |
| Forward PS | 4.31 |
| PB Ratio | 4.94 |
| P/TBV Ratio | 5.01 |
| P/FCF Ratio | 25.45 |
| P/OCF Ratio | 23.63 |
| PEG Ratio | 2.67 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 22.78, with an EV/FCF ratio of 24.53.
| EV / Earnings | 39.48 |
| EV / Sales | 5.00 |
| EV / EBITDA | 22.78 |
| EV / EBIT | 24.08 |
| EV / FCF | 24.53 |
Financial Position
The company has a current ratio of 3.13, with a Debt / Equity ratio of 0.19.
| Current Ratio | 3.13 |
| Quick Ratio | 2.79 |
| Debt / Equity | 0.19 |
| Debt / EBITDA | 0.85 |
| Debt / FCF | 1.00 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 12.43% and return on invested capital (ROIC) is 10.76%.
| Return on Equity (ROE) | 12.43% |
| Return on Assets (ROA) | 8.75% |
| Return on Invested Capital (ROIC) | 10.76% |
| Return on Capital Employed (ROCE) | 15.84% |
| Revenue Per Employee | $1.34M |
| Profits Per Employee | $169,889 |
| Employee Count | 1,800 |
| Asset Turnover | 0.67 |
| Inventory Turnover | 18.08 |
Taxes
In the past 12 months, NBIX has paid $160.40 million in taxes.
| Income Tax | 160.40M |
| Effective Tax Rate | 34.41% |
Stock Price Statistics
The stock price has decreased by -3.29% in the last 52 weeks. The beta is 0.24, so NBIX's price volatility has been lower than the market average.
| Beta (5Y) | 0.24 |
| 52-Week Price Change | -3.29% |
| 50-Day Moving Average | 115.12 |
| 200-Day Moving Average | 121.30 |
| Relative Strength Index (RSI) | 64.01 |
| Average Volume (20 Days) | 971,046 |
Short Selling Information
The latest short interest is 4.06 million, so 4.11% of the outstanding shares have been sold short.
| Short Interest | 4.06M |
| Short Previous Month | 4.03M |
| Short % of Shares Out | 4.11% |
| Short % of Float | 4.16% |
| Short Ratio (days to cover) | 2.61 |
Income Statement
In the last 12 months, NBIX had revenue of $2.41 billion and earned $305.80 million in profits. Earnings per share was $2.96.
| Revenue | 2.41B |
| Gross Profit | 1.54B |
| Operating Income | 501.40M |
| Pretax Income | 446.90M |
| Net Income | 305.80M |
| EBITDA | 529.90M |
| EBIT | 501.40M |
| Earnings Per Share (EPS) | $2.96 |
Balance Sheet
The company has $943.50 million in cash and $493.10 million in debt, giving a net cash position of $450.40 million or $4.55 per share.
| Cash & Cash Equivalents | 943.50M |
| Total Debt | 493.10M |
| Net Cash | 450.40M |
| Net Cash Per Share | $4.55 |
| Equity (Book Value) | 2.54B |
| Book Value Per Share | 25.61 |
| Working Capital | 1.12B |
Cash Flow
In the last 12 months, operating cash flow was $529.90 million and capital expenditures -$37.70 million, giving a free cash flow of $492.20 million.
| Operating Cash Flow | 529.90M |
| Capital Expenditures | -37.70M |
| Free Cash Flow | 492.20M |
| FCF Per Share | $4.97 |
Margins
Gross margin is 63.91%, with operating and profit margins of 20.78% and 12.68%.
| Gross Margin | 63.91% |
| Operating Margin | 20.78% |
| Pretax Margin | 19.32% |
| Profit Margin | 12.68% |
| EBITDA Margin | 21.96% |
| EBIT Margin | 20.78% |
| FCF Margin | 20.40% |
Dividends & Yields
NBIX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.78% |
| Shareholder Yield | -0.78% |
| Earnings Yield | 2.44% |
| FCF Yield | 3.93% |
Analyst Forecast
The average price target for NBIX is $163.20, which is 28.96% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $163.20 |
| Price Target Difference | 28.96% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 20 |
| Revenue Growth Forecast (5Y) | 12.02% |
| EPS Growth Forecast (5Y) | 35.48% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
NBIX has an Altman Z-Score of 8.35 and a Piotroski F-Score of 5.
| Altman Z-Score | 8.35 |
| Piotroski F-Score | 5 |